M.I.A. Koetsier

583 total citations
14 papers, 408 citations indexed

About

M.I.A. Koetsier is a scholar working on Immunology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, M.I.A. Koetsier has authored 14 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Dermatology and 5 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in M.I.A. Koetsier's work include Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). M.I.A. Koetsier is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (11 papers), Dermatology and Skin Diseases (6 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). M.I.A. Koetsier collaborates with scholars based in Netherlands and United States. M.I.A. Koetsier's co-authors include P.C.M. van de Kerkhof, J.M. Mommers, E.M.G.J. de Jong, M.D. Njoo, Marisol E. Otero, Paul M. Ossenkoppele, Wietske Kievit, W.P. Arnold, A.L.A. Kuijpers and Jeffrey Zweegers and has published in prestigious journals such as British Journal of Dermatology, Digestive Diseases and Sciences and Journal of the European Academy of Dermatology and Venereology.

In The Last Decade

M.I.A. Koetsier

14 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.I.A. Koetsier Netherlands 12 311 176 98 80 59 14 408
R. Jiménez‐Puya Spain 12 401 1.3× 232 1.3× 93 0.9× 59 0.7× 73 1.2× 28 567
R. Torrado Spain 11 314 1.0× 135 0.8× 108 1.1× 79 1.0× 53 0.9× 12 383
William N. Malatestinic United States 12 376 1.2× 192 1.1× 86 0.9× 65 0.8× 167 2.8× 53 516
Canelle Mazaud France 5 296 1.0× 173 1.0× 64 0.7× 40 0.5× 73 1.2× 6 390
Zarif K. Jabbar‐Lopez United Kingdom 10 217 0.7× 289 1.6× 41 0.4× 25 0.3× 92 1.6× 23 476
Claudia de la Cruz United States 9 160 0.5× 108 0.6× 23 0.2× 42 0.5× 43 0.7× 17 272
C. Horreau France 5 459 1.5× 203 1.2× 50 0.5× 15 0.2× 175 3.0× 6 604
M‐A Richard France 8 274 0.9× 182 1.0× 22 0.2× 22 0.3× 83 1.4× 13 416
L. Salgado‐Boquete Spain 10 178 0.6× 165 0.9× 30 0.3× 17 0.2× 36 0.6× 32 303
S. Jazayeri United States 7 412 1.3× 278 1.6× 36 0.4× 30 0.4× 73 1.2× 10 443

Countries citing papers authored by M.I.A. Koetsier

Since Specialization
Citations

This map shows the geographic impact of M.I.A. Koetsier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.I.A. Koetsier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.I.A. Koetsier more than expected).

Fields of papers citing papers by M.I.A. Koetsier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.I.A. Koetsier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.I.A. Koetsier. The network helps show where M.I.A. Koetsier may publish in the future.

Co-authorship network of co-authors of M.I.A. Koetsier

This figure shows the co-authorship network connecting the top 25 collaborators of M.I.A. Koetsier. A scholar is included among the top collaborators of M.I.A. Koetsier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.I.A. Koetsier. M.I.A. Koetsier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Berends, Sophie E., Hans Groenewoud, Ron A. A. Mathôt, et al.. (2022). Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. Journal of Dermatological Treatment. 33(5). 2680–2684. 8 indexed citations
2.
Hees, C.L.M. van, Hannelore I. Bax, Tom Sprong, et al.. (2022). Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease. Open Forum Infectious Diseases. 9(4). ofac077–ofac077. 12 indexed citations
3.
Reek, J.M.P.A. van den, Marisol E. Otero, M.D. Njoo, et al.. (2020). Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study. Acta Dermato Venereologica. 100(19). adv00340–adv00340. 12 indexed citations
4.
Reek, J.M.P.A. van den, Alfons A den Broeder, Lieke J. van Vugt, et al.. (2020). Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis. JAMA Dermatology. 156(4). 393–393. 34 indexed citations
5.
Reek, J.M.P.A. van den, J.M.M. Groenewoud, Marisol E. Otero, et al.. (2019). Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry. Journal of the European Academy of Dermatology and Venereology. 33(10). 1913–1920. 33 indexed citations
6.
7.
Zweegers, Jeffrey, J.M.M. Groenewoud, J. M. P. A. van den Reek, et al.. (2016). Comparison of the 1- and 5-year effectiveness of adalimumab, etanercept and ustekinumab in patients with psoriasis in daily clinical practice: results from the prospective BioCAPTURE registry. British Journal of Dermatology. 176(4). 1001–1009. 38 indexed citations
8.
Zweegers, Jeffrey, P.C.M. van de Kerkhof, J.M.P.A. van den Reek, et al.. (2016). Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort. British Journal of Dermatology. 176(3). 786–793. 41 indexed citations
9.
Koetsier, M.I.A. & P.C.M. van de Kerkhof. (2015). “Patient-centered treatment” for mild-to-moderate psoriasis. Journal of Dermatological Treatment. 26(1). 1–6. 22 indexed citations
10.
Reek, J.M.P.A. van den, Marisol E. Otero, Jeffrey Zweegers, et al.. (2014). Satisfaction of treatment with biologics is high in psoriasis: results from the Bio-CAPTURE network. British Journal of Dermatology. 170(5). 1158–1165. 24 indexed citations
11.
Reek, J. M. P. A. van den, Jeffrey Zweegers, Wietske Kievit, et al.. (2014). ‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTUREnetwork. British Journal of Dermatology. 171(5). 1189–1196. 77 indexed citations
12.
Zweegers, Jeffrey, J. M. P. A. van den Reek, Marisol E. Otero, et al.. (2014). Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: Bio CAPTURE. British Journal of Dermatology. 171(5). 1091–1098. 19 indexed citations
13.
Oijen, Martijn van, M.I.A. Koetsier, Robert J.F. Laheij, et al.. (2009). Genetic Polymorphisms in UDP-Glucuronosyltransferase 1A6 Are Not Associated with NSAIDs-Related Peptic Ulcer Haemorrhage. Drug Metabolism Letters. 3(3). 199–204. 3 indexed citations
14.
Oijen, Martijn G.H. van, Robert J.F. Laheij, M.I.A. Koetsier, et al.. (2006). Effect of a Specific Cyclooxygenase-Gene Polymorphism (A-842G/C50T) on the Occurrence of Peptic Ulcer Hemorrhage. Digestive Diseases and Sciences. 51(12). 2348–2352. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Jiménez‐Puya Breakdown of academic impact, for papers by R. Torrado Breakdown of academic impact, for papers by William N. Malatestinic Breakdown of academic impact, for papers by Canelle Mazaud Breakdown of academic impact, for papers by Zarif K. Jabbar‐Lopez Breakdown of academic impact, for papers by Claudia de la Cruz Breakdown of academic impact, for papers by C. Horreau Breakdown of academic impact, for papers by M‐A Richard Breakdown of academic impact, for papers by L. Salgado‐Boquete Breakdown of academic impact, for papers by S. Jazayeri
Rankless by CCL
2026